- We resume coverage on IHH Healthcare with BUY and SOTP-based target price of MYR7.97.
- Despite the strong performance of IHH Healthcare's share price year-to-date with gain of more than 20%, we believe there are still reasons to track IHH Healthcare in 2025. IHH Healthcare has clear growth drivers ahead of it, leveraging on higher demand and revenue intensity, especially in India and Malaysia. Valuations are also ripe for a re-rating, in our view.
- - Read this at SGinvestors.io -
3 reasons to look at IHH in 2025
- - Read this at SGinvestors.io -
- History has also evidenced that private healthcare is also a defensive industry in addition to being a growing one.
- We gather that IHH Healthcare’s valuations are ripe for a re-rating in 2025 with the touted listing of Sunway Healthcare and Columbia Asia Healthcare.
Growth opportunities – organic & inorganic
- Read more at SGinvestors.io.
Above is the excerpt from report by Maybank Research.
Clients of Maybank Securities may be the first to access the full report in PDF @ https://www.maybanktrade.com.sg/.
Yin Shao Yang Maybank Research | Nur Natasha Ariza Maybank Research | https://www.maybanktrade.com.sg/ 2024-12-27
Read also Maybank's most recent report:
2025-01-15 IHH Healthcare - Visible Value Creation From Northern Hospitals.
Price targets by 2 other brokers at IHH Healthcare Target Prices.
Listing of research reports at IHH Healthcare Analyst Reports.
Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividend Payout Dates & Corporate Actions,
IHH Healthcare News
